Scopolamine attenuates auditory cortex response

Acta Otolaryngol. 2015;135(11):1132-7. doi: 10.3109/00016489.2015.1064996. Epub 2015 Jul 4.

Abstract

Conclusion: Scopolamine, a tropane alkaloid drug that mainly acts as an antagonist of muscarinic acetylcholine receptors, was found to reduce the local field potentials (LFP) of auditory cortex (AC) evoked by tone and gap-offsets whose effects may compensate the cortical hyperexcitability related to tinnitus.

Objective: To study the effects of scopolamine on the AC and the inferior colliculus (IC) of awake rats in order to understand scopolamine's effect on tinnitus and gap detection.

Method: Silent gaps (duration varied from 2-100 ms) embedded in otherwise continuous noise were used to elicit AC and IC response. Gap evoked AC and IC field potentials were recorded from awake rats before and after treatment of scopolamine (3 mg/kg, i.m.).

Results: Acute injection of scopolamine (3 mg/kg, i.m.) induced a significant reduction of the AC response, but not the IC response, to the offset of the gaps embedded in white noise. The results suggest that scopolamine may reduce AC neural synchrony.

Keywords: Scopolamine; acetylcholine; auditory cortex; gap detection; tinnitus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acoustic Stimulation / methods
  • Animals
  • Auditory Cortex / drug effects*
  • Auditory Cortex / physiopathology
  • Auditory Threshold
  • Electrodes, Implanted
  • Evoked Potentials, Auditory / drug effects*
  • Inferior Colliculi
  • Injections
  • Male
  • Muscarinic Antagonists / administration & dosage
  • Rats
  • Rats, Sprague-Dawley
  • Scopolamine / administration & dosage*
  • Tinnitus / drug therapy*
  • Tinnitus / physiopathology

Substances

  • Muscarinic Antagonists
  • Scopolamine